Skip to main content
LGVN logo

Longeveron Inc. (LGVN)

LGVNNASDAQHealthcareBiotechnology

$1.66Today:−$0.09 (−5.21%)1Y +203.33%

As of Nov 20, 2026 close

Market cap
$5.84M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.48$8.90
Volume (live)
-
Avg. volume (3M)
90.25K

Longeveron (LGVN) Income Statement

Longeveron reported revenue of $1.20M in fiscal 2025 (fiscal year ended Dec 31, 2025), down 49.9% from $2.39M a year earlier. Longeveron posted a net loss of $22.70M, compared with a net loss of $24.62M a year earlier. Gross margin was 67.0% and operating margin −1942.2%. In the most recent quarter, Q3 fiscal 2026 (ended Sep 30, 2026), revenue was $115.00K, down 16.1% from the same quarter a year earlier.

Longeveron Income Statement Analysis

Values in millions USD

Scroll to see more
Longeveron Inc. income statement - Annual data in millions USD
BreakdownTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period endingSep 2026Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue1.171.202.390.711.221.315.635.632.13
Cost of Revenue0.390.400.510.490.730.723.803.801.45
Gross Profit0.770.801.880.220.500.591.831.830.68
Operating Expenses
Research & Development12.1912.048.149.079.377.092.672.673.88
Selling, General & Administrative12.1312.0510.2712.189.1710.952.932.933.17
Operating Expenses24.3224.0918.4121.2518.5418.055.605.607.04
Operating Income-23.54-23.29-16.52-21.03-18.04-17.46-3.78-3.78-6.36
Other Income/Expense
Interest Income-0.000.000.000.000.000.000.000.02
Interest Expense-0.000.000.000.000.00-0.010.000.00
Other Income/Expense1.150.580.55-0.38-0.790.410.060.060.02
Income
Income Before Tax-22.39-22.70-15.97-21.41-18.84-17.05-3.72-3.72-6.34
Income Tax Expense-0.000.000.000.000.000.000.000.02
Net Income-22.39-22.70-24.62-21.41-18.84-17.05-3.72-3.72-6.34
Net Income - Continuous Operations-22.39-22.70-15.97-21.41-18.84-17.05-3.72-3.72-6.34
Net Income - Discontinued Operations---------
EBITDA-22.53-22.06-15.56-20.47-17.15-16.13-2.99-2.95-5.59
EBIT-23.34-23.29-16.52-21.03-18.04-17.40-3.78--
Depreciation & Amortization0.981.230.960.950.890.910.790.770.75
Earnings Per Share
Basic EPS-8.29-12.90-26.16-102.00-90.00-90.00-2.00-19.00-40.00
Diluted EPS-8.29-12.90-26.16-102.00-90.00-90.00-2.00-19.00-40.00
Basic Shares Outstanding2.761.760.940.220.210.191.600.160.16
Diluted Shares Outstanding2.761.760.940.220.210.191.600.160.16

Source: Company financial statements from annual and quarterly filings. Data as of Sep 30, 2026. Data sources and methodology

Frequently Asked Questions About Longeveron Financial Statements

What was Longeveron's revenue in fiscal 2025?

Longeveron reported revenue of $1.20M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 49.9% from $2.39M a year earlier.

Is Longeveron profitable?

No. Longeveron reported a net loss of $22.70M in fiscal 2025. In fiscal 2024 it lost $24.62M.

What is Longeveron's operating margin?

Longeveron's operating income was −$23.29M on revenue of $1.20M in fiscal 2025, an operating margin of −1942.2%, compared with −690.7% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition